Organisation mondiale de la santé (OMS) · Technical Documents

WHO: Ebola situation report 21 October 2015

Organisation mondiale de la santé
Voir le document original

Le texte intégral est hébergé par l’organisation qui le publie. lawenc.com indexe les métadonnées et renvoie vers la source officielle.

Texte intégral

EBOLA SITUATION REPORT EBOLA SITUATION REPORT 21 OCTOBER 2015

SUMMARY  Three new confirmed cases of Ebola virus disease (EVD) were reported in the week to 18 October, all of which were reported in Guinea. The country had reported zero cases for the previous 2 weeks. Of the 3 new cases, 1 was reported from the capital, Conakry, and 2 were reported from the subprefecture of Kaliah, Forecariah. Of note, 2 cases were not registered contacts, 1 of whom was identified after post-mortem testing of a community death. There are currently 246 contacts under follow-up in Guinea (70 of whom are high risk), and an additional 253 contacts identified during the past 42 days remain untraced. Therefore there remains a nearterm risk of further cases among both registered and untraced contacts. Sierra Leone reported zero cases for a fifth consecutive week.  Case incidence has remained at 5 confirmed cases or fewer per week for 12 consecutive weeks. Over the same period, transmission of the virus has been geographically confined to several small areas in western Guinea and Sierra Leone, marking a transition to a distinct, third phase of the epidemic. The phase-3 response1 coordinated by the Interagency Collaboration on Ebola2 builds on existing measures to drive case incidence to zero, and ensure a sustained end to EVD transmission. Enhanced capacity to rapidly identify a reintroduction (either from an area of active transmission or from an animal reservoir), or re-emergence of virus from a survivor, and capacity for testing and counselling as part of a comprehensive package to safeguard the welfare of survivors are central to the phase-3 response framework.  The case from Conakry, a 21-year-old male, was reported from the Ratoma area of the city. However, he is not a known contact of a previous case, and genomic analyses suggest he was not infected with the strain of Ebola virus responsible for the most recent cases in Conakry and Forecariah. Investigations to identify the origin of infection are ongoing. The first case identified from Forecariah, a 35-year-old woman, was not a registered contact, and was identified after post-mortem testing of a community death. However, genomic analyses suggest she is part of the same chain of transmission—the Ratoma chain—as the 4 cases that were reported from the same subprefecture in Forecariah during the week ending 27 September 2015. The second case identified from Forecariah is her 3-month-old child, and was a registered contact. Of 246 contacts under follow-up in Guinea on 18 October, 43 were located in Conakry with the remainder located in Forecariah.  In Sierra Leone, all contacts linked to the country’s 2 most recently active chains of transmission, Bombali and Kambia, have completed 21-day follow-up. In addition, the last case to receive treatment was confirmed free of EVD after a second consecutive negative test on 25 September. The country will be declared free of EVD transmission on 7 November if no further cases are reported. However, 2 high-risk contacts—one from Bombali and one from Kambia—remain untraced. Efforts to trace these contacts will continue until 42 days have elapsed since the last reported case in each district.  Robust surveillance measures are essential to ensure the rapid detection of any reintroduction or reemergence of EVD in currently unaffected areas. Nine operational laboratories in Guinea tested a total of 654 new and repeat samples in the week to 18 October. In Liberia, 1278 new and repeat samples were tested over the same period in the country’s 4 operational laboratories. 1592 new samples were collected in Sierra Leone and tested by 8 operational laboratories. 1

Ebola response phase 3: Framework for achieving and sustaining a resilient zero: http://www.who.int/csr/resources/publications/ebola/ebola-responsephase3/en/ 2 See: http://www.who.int/csr/disease/ebola/situation-reports/ice-reports/en/

EBOLA SITUATION REPORT Figure 1: Confirmed, probable, and suspected EVD cases worldwide (data up to 18 October 2015)

Guinea Liberia Sierra Leone Italy Mali Nigeria Senegal Spain United Kingdom United States of America Total 1 0 8 6 20 8 1 0 1 0 1 0 4 1

2535

3803 4808 3955 10 672 14 001

11 313

28 512

COUNTRIES WITH WIDESPREAD AND INTENSE TRANSMISSION Table 1: Confirmed, probable, and suspected cases in Guinea, Liberia, and Sierra Leone Country Case definition Confirmed Guinea Probable Suspected Total Confirmed Probable Suspected Liberia** Total Confirmed Probable Suspected Total Confirmed Sierra Leone Probable Suspected Total Confirmed Total Probable Suspected Total Cumulative cases 3347 453 3 3803 3151 1879 5636 10 666 6 * ‡ 6 8704 287 5010 14 001 15 208 2619 10 649 28 476 Cases in past 21 days 3 * * 3 Cumulative deaths 2082 453 ‡ 2535 ‡ ‡ ‡ 4806 2 ‡ ‡ 2 3589 208 158 3955 ‡ ‡ ‡ 11 298

0 * * 0 0 * * 0 3 * * 3

Data are based on official information reported by ministries of health. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. *Not reported due to the high proportion of probable and suspected cases ‡ that are reclassified. Data not available. **Cases reported before 9 May 2015 are shaded blue. Due to ongoing surveillance and retrospective validation of cases and deaths, these totals may be subject to revision. Liberia was declared free of Ebola virus transmission in the human population on 3 September 2015, and has now entered a period of heightened surveillance.

EBOLA SITUATION REPORT  Since the beginning of the outbreak there have been a total of 28 476 reported confirmed, probable, and suspected cases3 of EVD in Guinea, Liberia, and Sierra Leone (figure 1, table 1) up to 18 October, with 11 298 reported deaths (this total includes reported deaths among probable and suspected cases, although outcomes for many cases are unknown). Three new cases were reported in the week to 18 October, all of which were from Guinea.

 The total number of confirmed cases is similar in males and females (table 2). Compared with children (people aged 14 years and under), adults aged 15 to 44 years of age are approximately four times more likely to be affected in Guinea and Liberia, and three times more likely to be affected in Sierra Leone. Adults aged 45 years and above are approximately five times more likely to be affected in Guinea, and approximately four times more likely in Liberia and Sierra Leone.  No new health worker infections were reported in the week to 18 October. Since the start of the outbreak a total of 881 confirmed health worker infections have been reported in Guinea, Liberia, and Sierra Leone; there have been 513 reported deaths (table 5).

Table 2: Cumulative number of confirmed cases by sex and age group in Guinea, Liberia, and Sierra Leone Cumulative cases By sex* By age group‡ Country (per 100 000 population) (per 100 000 population) Male Female 0–14 years 15–44 years 45+ years 1596 1743 532 1902 861 Guinea (29) (32) (11) (41) (55) 1911 1838 561 2060 703 § Liberia (96) (93) (33) (121) (132) 4823 5118 1992 5636 2140 Sierra Leone (169) (176) (82) (218) (290) Population figures are based on estimates from the United Nations Department of Economic and Social Affairs. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. *Excludes cases for which data § on sex are not available. ‡Excludes cases for which data on age are not available. Data are until 9 May 2015. 4

GUINEA  Key performance indicators for the EVD response in Guinea are shown in table 6.  Three confirmed cases were reported from Guinea during the week ending 18 October (table 3, table 4, figure 2, figure 3): 1 from the capital Conakry and 2 from the subprefecture of Kaliah in Forecariah.  The case from Conakry, a 21-year-old male, was reported from the Ratoma area of the city. However, he is not a known contact of a previous case, and genomic analyses suggest he was not infected with the strain of Ebola virus responsible for the most recent cases in Conakry and Forecariah. Investigations to identify the origin of infection are ongoing. The first case identified from Forecariah, a 35-year-old woman, was not a registered contact, and was identified after post-mortem testing of a community death. However, genomic analyses suggest she is part of the same chain of transmission—the Ratoma chain—as the 4 cases that were reported from the same subprefecture in Forecariah during the week ending 27 September 2015. The second case identified from Forecariah is her 3-month-old child, and was a registered contact.  Of the 246 contacts that were under follow-up in Guinea on 18 October, 43 were located in Conakry (7 of whom are high risk) with the remainder located in Forecariah (of whom 63 are high risk; table 3). In addition, 253 contacts identified during the past 42 days remain untraced.  The Ebola ça suffit! ring vaccination trial is continuing in Guinea. All rings comprised of contacts and contacts of contacts associated with confirmed cases now receive immediate vaccination with the rVSV-ZEBOV Ebola vaccine. Previously, rings were randomly allocated to receive either immediate vaccination or vaccination 21 3

Case definition recommendations for Ebola or Marburg Virus Diseases: http://www.who.int/csr/resources/publications/ebola/ebola-case-definitioncontact-en.pdf?ua=1 4

United Nations Department of Economic and Social Affairs: http://esa.un.org/unpd/wpp/Excel-Data/population.htm

EBOLA SITUATION REPORT days after the confirmation of a case. On 1 September, the eligibility criteria for the trial were amended to allow the vaccination of children aged 6 years and above.  There were 477 safe burials reported in Guinea out of 480 reported community deaths during the week to 18 October.  Including both initial and repeat testing, a total of 654 laboratory samples were tested in the week to 18 October. Most tests (88% in the week to 18 October) are of post-mortem swabs taken to rule out EVD as the cause of death (figure 7, figure 8). Analyses of the geographical distribution of samples tested indicate that no samples from live or dead suspected cases of EVD were tested from half (17 of 34) of Guinean prefectures during the week to 18 October (figure 7, figure 8). Most of the 17 prefectures with zero samples tested are located in the north and east of the country. Locations of the 9 operational laboratories in Guinea are shown in figure 8.  On 18 October, 31 of 34 Guinean prefectures reported at least one alert of a person or persons who showed any symptom compatible with EVD, or a community death.  Locations of the 8 operational Ebola treatment centres (ETCs) are shown in figure 6. No health worker infections were reported in the week to 18 October.

Table 3: Cases and contacts by district/prefecture over the past 3 weeks 12 13 14 15 Prefecture/ Week Oct Oct Oct Oct District 40 41 Conakry 0 0 0 1 0 0 Guinea Forecariah 0 0 0 0 1 0 Subtotal 0 0 0 1 1 0 0 Bombali 0 0 0 0 0 Sierra Leone Kambia 0 0 0 0 0 0 Subtotal 0 0 0 0 0 0 Total 0 0 0 1 1 0

16 Oct

17 Oct

18 Oct

Week 42 1 2 3 0 0 0 3

Contacts under follow up*

0 1 1 0 0 0 1

0 0 0 0 0 0 0

0 0 0 0 0 0 0

43 203 246 0 0 0 246

Data are based on official information reported by ministries of health. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. *Data as of 18 October 2015 for Guinea and Sierra Leone.

Table 4: Location and epidemiological status of confirmed cases reported in the 3 weeks to 18 October 2015 Country Prefecture/ District Conakry Forecariah Bombali Kambia Subprefecture/ Chiefdom Ratoma Kaliah Bombali Sebora Tonko Limba Week 40 (28 Sept 04 Oct 2015) 0 0 0 0 0 0 0 Week 41 (05 - 11 Oct 2015) 0 0 0 0 0 0 0 Cases 1 2 3 Week 42 (12 - 18 October 2015) On Unknown Confirmed Epicontact source of community link* list infection‡ death§ 1 1 1 1 1 0 2 1 Date of last confirmed case 13/10/2015 16/10/2015 13/09/2015 09/09/2015 0 3 0 1 0 0 0 2 0 1

Guinea Subtotal Sierra Leone Subtotal All

Sub-prefectures/chiefdoms that reported one or more confirmed cases in the 7 days to 18 October are highlighted. *Epi-link refers to cases who were not registered as contacts of a previous case (possibly because they refused to cooperate or were untraceable), but who, after further epidemiological investigation, were found to have had contact with a previous case, OR refers to cases who are resident or are from ‡ § a community with active transmission in the past 21 days. Includes cases under epidemiological investigation. A case that is identified as a community death can also be registered as a contact, or subsequently be found to have had contact with a known case (epi-link), or have no known link to a previous case.

EBOLA SITUATION REPORT Figure 2: Geographical distribution of confirmed cases reported in the week to 18 October 2015

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

EBOLA SITUATION REPORT

Table 5: Ebola virus disease infections in health workers in Guinea, Liberia, and Sierra Leone Country Cases Guinea Liberia* Sierra Leone Total 196 378 307 881

Deaths 100 192 221 ‡

513

Data are confirmed cases and deaths only, apart from deaths in Sierra Leone, which include confirmed, probable, and suspected deaths. ‡ *Data are until 9 May 2015. Data as of 17 February 2015.

Table 6: Key response performance indicators for Guinea

For definitions of key performance indicators see Annex 2. Data are given for 7-day periods. *Includes repeat samples. Data missing for 0–3% # of cases. Outcome data missing for 0–3% of hospitalized confirmed cases.

EBOLA SITUATION REPORT Table 7: Key response performance indicators for Sierra Leone

For definitions of key performance indicators see Annex 2. Data are for 7-day periods. Two unsafe burials were reported in Western Area in ‡ # the week to 11 October. Data missing for 7–14% of cases. Outcome data missing for 0–77% of hospitalized, confirmed cases.

§

SIERRA LEONE  Key performance indicators for the EVD response in Sierra Leone are shown in table 7.  No new confirmed cases were reported from Sierra Leone in the week to 18 October. This is the fifth consecutive week that the country has recorded zero cases.  All contacts linked to the country’s 2 most recently active chains of transmission, Bombali and Kambia, completed 21-day follow-up as of 4 October (the last case reported in Bombali was isolated on 12 September, before being reported as a case on 13 September). In addition, the last case to receive treatment was confirmed free of EVD after a second consecutive negative test on 25 September. However, 2 high-risk contacts—one from Bombali and one from Kambia—remain untraced. Efforts to trace these missing contacts and mitigate the risk of any undetected transmission will continue until at least 42 days have elapsed since the last reported case in each district.  The Ebola ça suffit! ring vaccination Phase 3 efficacy trial of the rVSV-ZEBOV vaccine was extended from Guinea to Sierra Leone in September. Contacts and contacts of contacts associated with new confirmed cases and who meet the trial’s eligibility criteria will therefore be offered the vaccine.

EBOLA SITUATION REPORT  Locations of the 10 operational Ebola treatment centres (ETCs) in Sierra Leone are shown in figure 6. No health worker infections were reported in the week to 18 October.  Laboratory indicators continue to reflect a heightened degree of vigilance, with 1592 new samples tested in the week to 18 October (table 7) from all 14 districts. Most tests (84% in the week to 18 October) are of postmortem swabs taken to rule out EVD as the cause of death (figure 7, figure 8).  In the week to 11 October (the most recent week for which data are available) there were 232 alerts of people who showed any symptom compatible with EVD, all of which were responded to within the same day. During the same period, there were 1549 notifications of burials, of which 1522 (98%) were responded to within the same day.  Locations of the 8 operational laboratories in Sierra Leone are shown in figures 7 and 8.

Figure 3: Geographical distribution of new and total confirmed cases in Guinea, Liberia, and Sierra Leone

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

EBOLA SITUATION REPORT Figure 4: Confirmed weekly Ebola virus disease cases reported nationally and by prefecture from Guinea

EBOLA SITUATION REPORT Figure 5: Confirmed weekly Ebola virus disease cases reported nationally and by district from Sierra Leone

EBOLA SITUATION REPORT Figure 6: Location of Ebola treatment centres and time since last confirmed case in Guinea, Liberia, and Sierra Leone

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

OTHER AFFECTED AND PREVIOUSLY AFFECTED COUNTRIES  Liberia was declared free of Ebola virus transmission in the human population on 3 September 2015, 42 days after the country’s last laboratory-confirmed case completed treatment and was confirmed as EVD-negative. It is now 99 days since symptom onset of the last reported confirmed case (figure 6). The country has now entered a 90-day period of heightened surveillance. 1278 samples were collected from all of the country’s 15 counties in the week to 18 October and tested in the country’s 4 operational laboratories. Seven countries (Italy, Mali, Nigeria, Senegal, Spain, the United Kingdom, and the United States of America) have previously reported a case or cases imported from a country with widespread and intense transmission. On 6 October 2015, a patient who was reported as a case in the United Kingdom on 29 December 2014, and who later recovered, was hospitalised in the United Kingdom after developing late EVD-related complications. As of 13 October, a total of 62 close contacts had been identified in the UK for follow-up, of whom 26 have received the rVSV-ZEBOV vaccine.

EBOLA SITUATION REPORT Figure 7: Location of laboratories and geographical distribution of samples from live patients in Guinea, Liberia, and Sierra Leone in the week to 18 October 2015

The analysis includes initial and repeat samples but excludes samples with unknown and incorrect testing weeks and samples with unknown or incorrect location information. EDPLN=Emerging and Dangerous Pathogens Laboratory Network. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. 2=CREMS Lab – Kindia; 5=EU Mobile Lab – Coyah; 6=IP France – Macenta; 8=K-Plan Mobile Lab – Forecariah; 9=IP Dakar – Conakry; 12=REDC Lab – Conakry; 14=K-Plan Mobile Lab – Conakry; 15=Boke Mobile Lab; 16=Tappita Lab – Nimba; 22=LIBR National Reference Lab/USAMRIID; 25=OIC-NMRC Mobile Lab Bong; 26=MOH Lab – Montserrado; 27=US-CDC Lab – Bo; 28=China-CDC Lab – Jui; 30=CPHRL/DTRA – Lakka; 31=EMDF/NICD – Lakka; 35=MOH/Emergency – PCMH/Freetown; 37=Nigeria Mobile Lab – Kambia; 40=PH England Mobile Lab – Kerry Town; 41=PH England Mobile Lab – Port Loko; 42=PH England Mobile Lab – Makeni; 43=PH England Mobile Lab – Kenema.

EBOLA SITUATION REPORT Figure 8: Location of laboratories and geographical distribution of samples from dead bodies in Guinea, Liberia, and Sierra Leone in the week to 18 October 2015

The analysis includes initial and repeat samples but excludes samples with unknown and incorrect testing weeks and samples with unknown or incorrect location information. EDPLN=Emerging and Dangerous Pathogens Laboratory Network. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. 2=CREMS Lab – Kindia; 5=EU Mobile Lab – Coyah; 6=IP France – Macenta; 8=K-Plan Mobile Lab – Forecariah; 9=IP Dakar – Conakry; 12=REDC Lab – Conakry; 14=K-Plan Mobile Lab – Conakry; 15=Boke Mobile Lab; 16=Tappita Lab – Nimba; 22=LIBR National Reference Lab/USAMRIID; 25=OIC-NMRC Mobile Lab Bong; 26=MOH Lab – Montserrado; 27=US-CDC Lab – Bo; 28=China-CDC Lab – Jui; 30=CPHRL/DTRA – Lakka; 31=EMDF/NICD – Lakka; 35=MOH/Emergency – PCMH/Freetown; 37=Nigeria Mobile Lab – Kambia; 40=PH England Mobile Lab – Kerry Town; 41=PH England Mobile Lab – Port Loko; 42=PH England Mobile Lab – Makeni; 43=PH England Mobile Lab – Kenema.

PREPAREDNESS OF COUNTRIES TO RAPIDLY DETECT AND RESPOND TO AN EBOLA EXPOSURE  The introduction of an EVD case into unaffected countries remains a risk as long as cases exist in any country. With adequate preparation, however, such an introduction can be contained through a timely and effective response.  WHO’s preparedness activities aim to ensure all countries are ready to effectively and safely detect, investigate, and report potential EVD cases, and to mount an effective response. WHO provides this support

EBOLA SITUATION REPORT through country support visits by preparedness-strengthening teams (PSTs) to help identify and prioritize gaps and needs, direct technical assistance, and provide technical guidance and tools.

Priority countries in Africa  The initial focus of support by WHO and partners is on highest priority countries – Côte d’Ivoire, Guinea-Bissau, Mali, and Senegal—followed by high priority countries—Benin, Burkina Faso, Cameroon, Central African Republic, Democratic Republic of the Congo, Ethiopia, Gambia, Ghana, Mauritania, Niger, Nigeria, South Sudan, and Togo. The criteria used to prioritize countries include the geographical proximity to affected countries, the magnitude of trade and migration links, and the relative strength of their health systems.  Since 20 October 2014, PSTs have provided technical support in Benin, Burkina Faso, Cameroon, Central African Republic, Côte d’Ivoire, Ethiopia, Gambia, Ghana, Guinea-Bissau, Mali, Mauritania, Niger, Senegal, South Sudan, and Togo. Technical working group meetings, field visits, high-level table-top exercises, and field simulations have helped to identify key areas for improvement. Each country has a tailored plan to strengthen operational readiness.  From October 2014 to October 2015, WHO has undertaken over 290 field deployments to priority countries to assist with the implementation of national plans.  WHO provides personal protective equipment (PPE) modules containing minimum stocks to cover staff protection and other equipment needs to support 10 patient-beds for 10 days for all staff with essential functions. PPE modules have been delivered or are in the process of being delivered to all countries on the African continent. In addition, all countries have received a PPE training module.  Contingency stockpiles of PPE are in place in the United Nations Humanitarian Response Depots (UNHRD) in Accra and Dubai, and are available to any country in the event that they experience a shortage.

Follow-up support to priority countries  Following initial PST assessment missions to the priority countries in 2014, a second phase of preparednessstrengthening activities have provided support on a country-by-country basis. Activities in the week to 21 October are highlighted below.  International Health Regulations (IHR 2005) training on screening at points of entry was provided for over 30 participants in Mauritania from 28 September to 2 October. The training was supported by the WHO Country Office and the country’s ministry of health.  An Infection Prevention and Control (IPC) specialist to support infection control activities was deployed to Benin on 12 October until 30 October 2015.  In Guinea-Bissau, preparedness support continues to be provided at the central level, and in two priority regions (Tombali and Gabu) through WHO sub-offices. In regional health centres, training was provided on the correct use of infrared thermometers. A regional EVD coordination meeting was held on 15 October 2015, in the region of Gabu. An update on all field activities was done with WHO providing technical guidance. A field coordinator, two epidemiologists, and a logistician are currently deployed to the country.  Togo, Niger, and Mauritania, with support from WHO, are in the process of planning for national and regional rapid-response team training to be conducted between November and December 2015.

EVD preparedness officers  Dedicated EVD preparedness officers have been deployed to support the implementation of country preparedness plans, coordinate partners, provide a focal point for inter-agency collaboration, offer specific technical support in their respective areas of expertise, and develop capacity of national WHO staff. Preparedness officers are currently deployed to Benin, Burkina Faso, Cameroon, Central African Republic, Côte d’Ivoire, Ethiopia, Gambia, Ghana, Guinea-Bissau, Mali, Mauritania, Niger, Senegal, and Togo.

EBOLA SITUATION REPORT Training, exercises, and simulations  Priority countries that have achieved a minimum of 50% implementation of preparedness checklist activities are encouraged to undertake a series of drills on elements of an EVD response and a functional exercise to test the coordination of the Ebola operations centre.  Simulation exercises aimed at testing preparedness capabilities are being planned for Benin, Burkina Faso, Ethiopia, Guinea-Bissau, Mauritania, Niger and Togo and will start in the coming weeks or months.  Ghana completed the simulation exercise to review the coordination mechanisms through its emergency operations centre (EOC) last week.

Surveillance and preparedness indicators  Indicators based on surveillance data, case-management capacity, laboratory testing, and equipment stocks continue to be collected on a weekly basis from the four countries that share a border with affected countries: Côte d’Ivoire, Guinea-Bissau, Mali, and Senegal.  An interactive preparedness dashboard based on the WHO EVD checklist5 is available online.

ANNEX 1: COORDINATION OF THE EBOLA RESPONSE WHO continues to work with many partners in response to the EVD outbreak, including the African Union, the Economic Community of West African States, the Mano River Union, national governments, non-governmental organizations, UN agencies, and technical institutions and networks in the Global Outbreak Alert and Response Network (GOARN). Agencies responsible for coordinating 4 key lines of action in the response are given below. Lines of action Case management Case finding, laboratory services, and contact tracing Safe and dignified burials Lead agency WHO WHO International Federation of Red Cross and Red Crescent Societies (IFRC)

Community engagement and social mobilization UNICEF

5 4

See: http://who.int/csr/resources/publications/ebola/ebola-preparedness-checklist/en/ See: http://apps.who.int/ebola/preparedness/map

EBOLA SITUATION REPORT ANNEX 2: DEFINITION OF KEY PERFORMANCE INDICATORS FOR PHASE 2 OF THE EBOLA RESPONSE Indicator Cases and deaths Number of confirmed cases Number of confirmed deaths Number of confirmed deaths that occurred in the community Diagnostic Services Number of samples tested and percentage with positive EVD results Contact tracing Percent of new confirmed cases from registered contacts Hospitalization Time between symptom onset and hospitalization (days) Outcome of treatment Case fatality rate (among hospitalized cases) # of deaths among hospitalized cases (confirmed) # of hospitalized cases (confirmed) with a definitive survival outcome recorded Clinical investigation records Time between symptom onset and hospitalization of confirmed, probable or suspected cases (geometric mean number of days) # of confirmed cases Guinea: Daily WHO situation reports Sierra Leone: Daily Ministry of Health Ebola situation reports Guinea: Daily WHO situation reports Sierra Leone: Daily Ministry of Health Ebola situation reports Guinea: Weekly WHO situation reports Sierra Leone: Daily Ministry of Health N/A

Numerator

Numerator source

Denominator

Denominator source Jan

N/A

# of confirmed deaths # of deaths that occurred in the community with positive EVD swab results 18 Jan

N/A

N/A

N/A

N/A 25 Jan

# of new samples tested # of new samples tested with a positive EVD result 18 Jan

Guinea: Laboratory database Sierra Leone: Daily Ministry of Health Ebola situation reports

N/A # of new samples tested

Guinea: Laboratory database Sierra Leone: Daily Ministry of Health Ebola situation reports 25 Jan

# of new confirmed cases registered as a contact

Guinea: Weekly WHO situation reports Sierra Leone: Weekly Ministry of Health Surveillance Report

# of new confirmed cases

Guinea: Daily WHO situation reports Sierra Leone: Daily Ministry of Health Ebola situation Reports

Clinical investigation records

N/A

N/A

Clinical investigation records

Infection Prevention and Control (IPC) and Safety18 Jan25 Jan Number of newly Guinea: Daily WHO situation reports # of newly infected health infected health Sierra Leone: Daily Ministry of Health workers workers Ebola situation Reports Safe and dignified burials18 Ja25 Jan # of reports/alerts of Guinea: Daily WHO situation reports Number of unsafe burials that were not Sierra Leone: Ministry of Health burials reported known to be safe situation reports 18 Jan Social mobilization Number of districts # of districts with at least with at least one one security incident or Guinea: Daily WHO situation reports security incident or other form of refusal to Sierra Leone: UNICEF other form of refusal cooperate in the past week to cooperate

N/A

N/A

N/A Jan

N/A 18 Jan25 Jan

N/A

N/A

Informations clés
Type de document Technical Documents
Date d'adoption
Source Organisation mondiale de la santé